Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prostate cancer screening with prostate-specific antigen testing: more answers or more confusion?

× No keyword cloud information.

7 in total

1. Tumor-suppressive microRNA-497 targets IKKβ to regulate NF-κB signaling pathway in human prostate cancer cells.

Authors: Xiang-Jie Kong; Liu-Jian Duan; Xiao-Qiang Qian; Ding Xu; Hai-Long Liu; Ying-Jian Zhu; Jun Qi
Journal: Am J Cancer Res Date: 2015-04-15 Impact factor: 6.166

2. High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer.

Authors: Shoumin Bai; Ting Chen; Tao Du; Xianju Chen; Yiming Lai; Xiaoming Ma; Wanhua Wu; Chunhao Lin; Leyuan Liu; Hai Huang
Journal: Oncol Lett Date: 2017-09-22 Impact factor: 2.967

3. microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.

Authors: Xiangjie Kong; Xiaoqiang Qian; Liujian Duan; Hailong Liu; Yingjian Zhu; Jun Qi
Journal: DNA Cell Biol Date: 2016-09-27 Impact factor: 3.311

4. Utilization of prostate cancer screening according to dietary patterns and other demographic variables. The adventist health study-2.

Authors: Yermek Ibrayev; Keiji Oda; Gary E Fraser; Synnove F Knutsen
Journal: J Cancer Date: 2013-06-28 Impact factor: 4.207

Prostate cancer screening with prostate-specific antigen testing: more answers or more confusion?

1. Tumor-suppressive microRNA-497 targets IKKβ to regulate NF-κB signaling pathway in human prostate cancer cells.

2. High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer.

3. microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.

4. Utilization of prostate cancer screening according to dietary patterns and other demographic variables. The adventist health study-2.

5. Clinical significance of NUCB2 mRNA expression in prostate cancer.

6. The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients.

7. Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.